Health Effects of Mold in Children

Pediatric Clinics of North America

Volumn 54, Issue 2, 2007, Pages 309-333

  Seltzer, James M ^a,b   Fedoruk, Marion J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; EPITOPE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MYCOTOXIN; ORGANIC MATTER; PRECIPITIN;

ALLERGIC ASTHMA; ALLERGIC PNEUMONITIS; ALLERGIC RHINITIS; ALLERGY; ALTERNARIA; ASPERGILLUS; ASTHMA; AUREOBASIDIUM; BRONCHOPULMONARY ASPERGILLOMA; CHILD HEALTH; CLADOSPORIUM; CLINICAL FEATURE; DISEASE ASSOCIATION; EOSINOPHILIA; FUNGUS GROWTH; FUNGUS HYPHAE; FUSARIUM; HUMAN; HYPERSENSITIVITY REACTION; IMMUNITY; INFECTION; LUNG LAVAGE; MOULD; MYCELIUM; PENICILLIUM; QUALITY OF LIFE; REVIEW; RHODOTORULA; SINUSITIS; SKIN IRRITATION; SYMPTOMATOLOGY; TRICHOSPORON CUTANEUM;

AIR POLLUTION, INDOOR; ASTHMA; CAUSALITY; CHILD; CHILD WELFARE; ENVIRONMENTAL MICROBIOLOGY; ENVIRONMENTAL MONITORING; EVIDENCE-BASED MEDICINE; FUNGI; HEALTH STATUS; HOUSING; HUMANS; HUMIDITY; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; INHALATION EXPOSURE; PEDIATRICS; UNITED STATES;

EID: 34247259488     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.02.001     Document Type: Review

References (159)

1. Spengler J., Neas L., Nakai S., et al. Respiratory symptoms and housing characteristics. Indoor Air 4 (1994) 72-82
2. Nevalainen A., and Seuri M. Of microbes and men. Indoor Air 15 Suppl 9 (2005) 58-64
3. Portnoy J., Kwak K., Dowling P., et al. Health effects of indoor fungi. Ann Allergy 94 (2005) 313-320
4. Fung F., and Hughson W. Health effects of indoor fungal bioaerosol exposure. Appl Occup Environ Hyg 18 (2003) 535-544
5. Bush R., Portnoy J., Saxon A., et al. The medical effects of mold exposure. J Allergy Clin Immunol 117 2 (2006) 326-333
6. Institute of Medicine of the National Academies. Damp indoor spaces and health (2004), The National Academies Press, Washington, DC
7. Kuhn D., and Ghannoum M. Indoor mold, toxigenic fungi, and Stachybotrys Chartarum: infectious disease perspective. Clin Microbiol Rev 16 1 (2003) 144-172
8. Horner W., Helbling A., Salvaggio J., et al. Fungal allergens. Clin Microbiol Rev 8 2 (1995) 161-179
9. Taskinen T., Hyvarinen A., Meklin T., et al. Asthma and respiratory infections in school children with special reference to moisture and mold problems in the school. Acta Paediatr 88 (1999) 1373-1379
10. Halonen M., Stern D., Wright A., et al. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 155 (1997) 1356-1361
11. O'Connor G., Walter M., Mitchell H., et al. Airborne fungi in the homes of children with asthma in low-income urban communities: the Inner-City Asthma Study. J Allergy Clin Immunol 114 (2004) 599-606
12. Eggleston P., Rosenstreich D., Lynn H., et al. Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 102 (1998) 563-570
13. Arbes S., Gergen P., Elliott L., et al. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 116 (2005) 377-383
14. Bush R., and Prochnau J. Alternaria-induced asthma. J Allergy Clin Immunol 113 (2004) 227-234
15. Bush R., and Portnoy J. The role and abatement of fungal allergens in allergic diseases. J Allergy Clin Immunol 107 (2001) S430-S440
16. Bobbitt R., Crandall M., Venkataraman A., et al. Characterization of a population presenting with suspected mold-related health effects. Ann Allergy 94 (2005) 39-44
17. Blackley C. Experimental research on the cause and nature of Catarrhus Aesitivus (hay fever or hay asthma) (1873), Bailliere, Tindal and Cox, London [revised edition, London, Dawson Pall Mall, 1959]
18. Cantani V., and Ciaschi V. Epidemiology of Alternaria alternata allergy: a prospective study of 6840 Italian asthmatic children. Eur Rev Med Pharmacol Sci 8 (2004) 289-294
19. Nelson H., Szefler S., Jacobs J., et al. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 104 (1999) 775-785
20. Perzanowski M., Sporik R., Squillace S., et al. Association of sensitization to Alternaria allergens with asthma among school-age children. J Allergy Clin Immunol 101 (1998) 626-632
21. Sanchez H., and Bush R. A review of Alternaria alternata sensitivity. Rev Iberoam Micol 18 (2001) 56-59
22. O'Hollaren M.T., Yunginger J.W., Offord K.P., et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 324 6 (1991) 359-363
23. Nilsson D., and Aas K. Immunological specificity and correlation of diagnostic tests for bronchial allergy to Cladosporium herbarum. Acta Paediatr Scand 65 (1976) 33-38
24. Zock J., Jarvis D., Luczynska C., et al. Housing characteristics, reported mold exposure, and asthma in the European Community Respiratory Health Survey. J Allergy Clin Immunol 110 (2002) 285-292
25. Malling H., Dreborg S., and Weeke B. Diagnosis and immunotherapy of mold allergy. III. Allergy 41 (1986) 507-519
26. Dreborg S., Agrell B., Foucard T., et al. A double-blind, multicenter immunotherapy trial in children using a purified and standardized Cladosporium preparation. Allergy 41 (1986) 131-140
27. Malling H., Dreborg S., and Weeke B. Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium. Allergy 42 4 (1987) 305-314
28. Horst M., Hejjaoui A., Horst V., et al. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 85 (1990) 460-472
29. Cantani A., Businco E., and Maglio A. Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Allergol Immunopathol (Madr) 16 1 (1988) 1-4
30. Bernardis P., Agnoletto M., Puccinelli P., et al. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 6 1 (1996) 55-62
31. Kidon I., See Y., Goh A., et al. Aeroallergen sensitization in pediatric allergic rhinitis in Singapore: is air-conditioning a factor in the tropics?. Pediatr Allergy Immunol 15 (2004) 340-343
32. Volovitz B., Osur S.L., Bernstein J.M., et al. Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children. J Allergy Clin Immunol 82 3 Pt 1 (1988) 414-418
33. Stark P., Celedon J., Chew G., et al. Fungal levels in the home and allergic rhinitis by 5 years of age. Environ Health Perspect 113 (2005) 1405-1409
34. Huang S.-W., and Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol 87 (2001) 350-355
35. Huang S.W. The risk of sinusitis in children with allergic rhinitis. Allergy Asthma Proc 21 2 (2000) 85-88
36. Wilken J.A., Berkowitz R., and Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol 89 4 (2002) 372-380
37. Dunleavy R.A., and Baade L.E. Neuropsychological correlates of severe asthma in children 9-14 years old. J Consult Clin Psychol 48 2 (1980) 214-219
38. Bender B.G. Cognitive effects of allergic rhinitis and its treatment. Immunol Allergy Clin North Am 25 2 (2005) 301-312 [vi-vii]
39. Dykewicz M.S., and Fineman S. Executive summary of joint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol 81 5 Pt 2 (1998) 463-468
40. Wananukul S., Huiprasert P., and Pongprasit P. Eczematous skin reaction from patch testing with aeroallergens in atopic children without atopic dermatitis. Pediatr Dermatol 10 3 (1993) 209-213
41. Clark R., and Adinoff A. Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool. J Am Acad Dermatol 21 (1989) 863-869
42. Sampson H. The role of "allergy" in atopic dermatitis. Clin Rev Allergy 4 (1986) 125-138
43. Drouet M., and Bouillaud E. Anaphylactic reaction to Aspergillus. Allerg Immunol (Paris) 28 3 (1996) 88-89
44. Torricelli R., Johansson S., and Withrich B. Ingestive and inhalative allergy to the mushroom Boletus edulis. Allergy 52 7 (1997) 747-751
45. Maibach H. Contact urticaria syndrome from mold on salami casing. Contact Derm 32 2 (1995) 120-121
46. Turner E., Greenberger P.A., and Sider M. Complexities of establishing an early diagnosis of allergic bronchopulmonary aspergillosis in children. Allergy Proc 10 1 (1989) 63-69
47. McCarthy D., and Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology: (2) skin, nasal and bronchial tests. Clin Allergy 1 (1971) 415-432
48. Greenberger P., et al. Allergic bronchopulmonary aspergillosis. In: Adkinson Jr. N., Yunginger J., and Busse W. (Eds). Middleton's allergy principles & practice, vol 2. 6th edition (2003), Mosby, Philadelphia 1353-1371
49. Knutsen A., Blakeslee N., Manoj R., et al. Allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis: diagnostic criteria when the IgE level is less than 500 IU/ml. Ann Allergy 95 (2005) 488-493
50. Laufer P., Fink J., Bruns W., et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 73 1 pt 1 (1984) 44-48
51. Greenberger P.A., and Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 81 4 (1988) 646-650
52. Imbeau S., Cohen M., and Reed C. Allergic bronchopulmonary aspergillosis in infants. Am J Dis Child 131 (1977) 1127-1130
53. Saini S., Boas S., Jerah A., et al. Allergic bronchopulmonary mycosis to Fusarium vasinfectum in a child. Ann Allergy 80 (1998) 377-380
54. Donnelly S., McLaughlin H., and Brendin C. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88. Ir J Med Sci 160 9 (1991) 288-290
55. Katzenstein A., Sale S., and Greenberger P.A. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 72 1 (1983) 89-93
56. Kupferberg S., and Bent J. Allergic fungal sinusitis in the pediatric population. Arch Otolaryngol Head Neck Surg 122 (1996) 1381-1384
57. deShazo R., and Swain R. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 96 1 (1995) 24-35
58. Marple B.F. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 111 6 (2001) 1006-1019
59. Schubert M. Medical treatment of allergic fungal sinusitis. Ann Allergy 85 (2000) 90-101
60. McClay J, Marple B. Allergic fungal sinusitis. 2006. Available at: http://www.emedicine.com/ent/topic510.htm.
61. McClay J., Marple B., Kapadia L., et al. Clinical presentation of allergic fungal sinusitis in children. Laryngoscope 112 (2002) 565-569
62. Chhabra A., Handa K.K., Chakrabarti A., et al. Allergic fungal sinusitis: clinicopathological characteristics. Mycoses 39 11-12 (1996) 437-441
63. Muntz H. Allergic fungal sinusitis in children. Otolaryngol Clin North Am 29 1 (1996) 185-192
64. Fan L. Hypersensitivity pneumonitis in children. Curr Opin Pediatr 14 (2002) 323-326
65. Greenberger P.A. Mold-induced hypersensitivity pneumonitis. Allergy Asthma Proc 25 4 (2004) 219-223
66. Chiron C., Gaultier C., Boule M., et al. Lung function in children with hypersensitivity pneumonitis. Eur J Respir Dis 65 (1984) 79-91
67. Fink J.N., Schlueter D.P., Sosman A.J., et al. Clinical survey of pigeon breeders. Chest 62 3 (1972) 277-281
68. Ratjen F., Costabel U., Griese M., et al. Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis. Eur Respir J 21 (2003) 144-148
69. Aebischer C.C., Frey U., and Schoni M.H. Hypersensitivity pneumonitis in a five-year-old boy: an unusual antigen source. Pediatr Pulmonol 33 1 (2002) 77-78
70. O'Connell E.J., Zora J.A., Gillespie D.N., et al. Childhood hypersensitivity pneumonitis (farmer's lung): four cases in siblings with long-term follow-up. J Pediatr 114 6 (1989) 995-997
71. Jacobs R., Thorner R., Holcomb J., et al. Hypersensitivity pneumonitis caused by Cladosporium in an enclosed hot-tub area. Ann Intern Med 105 2 (1986) 204-206
72. Hogan M.B., Patterson R., Pore R.S., et al. Basement shower hypersensitivity pneumonitis secondary to Epicoccum nigrum. Chest 110 3 (1996) 854-856
73. Lee S.-K., Kim S.-S., Nahm D.-H., et al. Hypersensitivity pneumonitis caused by Fusarium napiforme in a home environment. Allergy 55 (2000) 1190-1193
74. Sugiyama K., Mukae H., Ishii H., et al. Familial summer-type hypersensitivity pneumonitis-case report and review of literature. Nihon Kokyuki Gakkai Zasshi 43 11 (2005) 683-688
75. Iyori J., Kawamura K., and Seo K. Summer-type hypersensitivity pneumonitis in a child. Acta Paediatr Jpn 33 4 (1991) 488-491
76. Roeder A., Kirschning C.J., Rupec R.A., et al. Toll-like receptors and innate antifungal responses. Trends Microbiol 12 1 (2004) 44-49
77. Roeder A., Kirschning C.J., Rupec R.A., et al. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 42 6 (2004) 485-498
78. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 118 2-3 (2006) 137-144
79. Wan G.-H., Li C.-S., Guo S.-P., et al. An airborne mold-derived product, β-1,3-D-glucan, potentiates airway allergic responses. Eur J Immunol 29 (1999) 2491-2497
80. Hohl T., Van Epps H., Rivera A., et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLos Pathog 1 (2005) 232-240
81. Fogelmark B., Goto H., Yuasa K., et al. Acute pulmonary toxicity of inhaled β -1,3-glucan and endotoxin. Agents Actions 35 1-2 (1992) 50-56
82. Holt P. Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model. Environ Health Perspect 107 Suppl 3 (1999) 485-487
83. Thorn J., Beijer L., and Rylander R. Effects after inhalation of (1→3)- β - D-glucan in healthy humans. Mediators Inflamm 10 (2001) 173-178
84. Beijer L., Thorn J., and Rylander R. Effects after inhalation of (1→3) - β - D - glucan and relation to mould exposure in the home. Mediators Inflamm 11 3 (2002) 149-153
85. Beijer L., Thorn J., and Rylander R. Mould exposure at home relates to inflammatory markers in blood. Eur Respir J 21 (2003) 317-392
86. Hirvonen M.R., Huttunen K., and Roponen M. Bacterial strains from moldy buildings are highly potent inducers of inflammatory and cytotoxic effects. Indoor Air 15 Suppl 9 (2005) 65-70
87. Douwes J. (1→3)-β-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 15 (2005) 160-169
88. Kheradmand F., Kiss A., Xu J., et al. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 169 10 (2002) 5904-5911
89. Kauffman H.F., Tomee J.F., van de Riet M.A., et al. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105 6 Pt 1 (2000) 1185-1193
90. Johanning E., Biagini R., Hull D., et al. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 68 4 (1996) 207-218
91. Hodgson M.J., Morey P., Leung W.Y., et al. Building-associated pulmonary disease from exposure to Stachybotrys chartarum and Aspergillus versicolor. J Occup Environ Med 40 3 (1998) 241-249
92. Burge H.A. Fungi: toxic killers or unavoidable nuisances?. Ann Allergy Asthma Immunol 87 6 Suppl 3 (2001) 52-56
93. Etzel R.A. Mycotoxins. JAMA 287 4 (2002) 425-427
94. Robbins C.A., Swenson L.J., Nealley M.L., et al. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg 15 10 (2000) 773-784
95. Page E.H., and Trout D.B. The role of Stachybotrys mycotoxins in building-related illness. AIHAJ 62 5 (2001) 644-648
96. Hardin B.D., Kelman B.J., and Saxon A. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med 45 5 (2003) 470-478
97. Montalbano M., and Lemanske R. Infections and asthma in children. Curr Opin Pediatr 14 3 (2002) 334-337
98. Kelman B.J., Robbins C.A., Swenson L.J., et al. Risk from inhaled mycotoxins in indoor office and residential environments. Int J Toxicol 23 1 (2004) 3-10
99. Jarvis B.B., and Miller J.D. Mycotoxins as harmful indoor air contaminants. Appl Microbiol Biotechnol 66 4 (2005) 367-372
100. Etzel R.A., Montana E., Sorenson W.G., et al. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152 8 (1998) 757-762
101. Centers for Disease Control. Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 46 2 (1997) 33-35
102. Dearborn D.G., Smith P.G., Dahms B.B., et al. Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics 110 3 (2002) 627-637
103. Elidemir O., Colasurdo G.N., Rossmann S.N., et al. Isolation of Stachybotrys from the lung of a child with pulmonary hemosiderosis. Pediatrics 104 4 Pt 1 (1999) 964-966
104. Etzel R.A. Stachybotrys. Curr Opin Pediatr 15 1 (2003) 103-106
105. Yike I., and Dearborn D.G. Pulmonary effects of Stachybotrys chartarum in animal studies. Adv Appl Microbiol 55 (2004) 241-273
106. Yike I., Rand T.G., and Dearborn D.G. Acute inflammatory responses to Stachybotrys chartarum in the lungs of infant rats: time course and possible mechanisms. Toxicol Sci 84 2 (2005) 408-417
107. Fung F., and Clark R.F. Health effects of mycotoxins: a toxicological overview. J Toxicol Clin Toxicol 42 2 (2004) 217-234
108. Belson M.G., Schier J.G., and Patel M.M. Case definitions for chemical poisoning. MMWR Recomm Rep 54 RR-1 (2005) 1-24
109. Trout D.B., Seltzer J.M., Page E.H., et al. Clinical use of immunoassays in assessing exposure to fungi and potential health effects related to fungal exposure. Ann Allergy Asthma Immunol 92 5 (2004) 483-491 [quiz: 492-4, 575]
110. Gilbert J., Brereton P., and MacDonald S. Assessment of dietary exposure to ochratoxin A in the UK using a duplicate diet approach and analysis of urine and plasma samples. Food Addit Contam 18 12 (2001) 1088-1093
111. Meky F.A., Turner P.C., Ashcroft A.E., et al. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol 41 2 (2003) 265-273
112. Von Essen S., Robbins R.A., Thompson A.B., et al. Organic dust toxic syndrome: an acute febrile reaction to organic dust exposure distinct from hypersensitivity pneumonitis. J Toxicol Clin Toxicol 28 4 (1990) 389-420
113. Rask-Andersen A. Organic dust toxic syndrome among farmers. Br J Ind Med 46 4 (1989) 233-238
114. Brinton W.T., Vastbinder E.E., Greene J.W., et al. An outbreak of organic dust toxic syndrome in a college fraternity. JAMA 258 9 (1987) 1210-1212
115. Latge J.P., and Calderone R. Host-microbe interactions: fungi invasive human fungal opportunistic infections. Curr Opin Microbiol 5 4 (2002) 355-358
116. Groll A.H., and Walsh T.J. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect 7 Suppl 2 (2001) 8-24
117. Weems Jr. J.J., Davis B.J., Tablan O.C., et al. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control 8 2 (1987) 71-75
118. Perraud M., Piens M.A., Nicoloyannis N., et al. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiol Infect 99 2 (1987) 407-412
119. Krasinski K., Holzman R.S., Hanna B., et al. Nosocomial fungal infection during hospital renovation. Infect Control 6 7 (1985) 278-282
120. Buffington J., Reporter R., Lasker B.A., et al. Investigation of an epidemic of invasive aspergillosis: utility of molecular typing with the use of random amplified polymorphic DNA probes. Pediatr Infect Dis J 13 5 (1994) 386-393
121. Sehulster L., and Chinn R.Y. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52 RR-10 (2003) 1-42
122. Shusterman D. Toxicology of nasal irritants. Curr Allergy Asthma Rep 3 (2003) 258-265
123. Veronesi B., and Oortgiesen M. Neurogenic inflammation and particulate matter (PM) air pollutants. Neurotoxicology 22 (2001) 795-810
124. Widdicombe J. Afferent receptors in the airways and cough. Respir Physiol 114 (1998) 5-15
125. Cometto-Muniz J., and Cain W. Physicochemical determinants and functional properties of the senses of irritation and smell. In: Gammage R., and Berven B. (Eds). Indoor air and human health. 2nd edition (1996), CRC Press, New York 53-65
126. Nilsson A., Kihlstrom E., Lagesson V., et al. Microorganisms and volatile organic compounds in airborne dust from damp residences. Indoor Air 14 (2004) 74-82
127. Saijo Y., Kishi R., Sata F., et al. Symptoms in relation to chemicals and dampness in newly built dwellings. Int Arch Occup Environ Health 77 (2004) 461-470
128. Laumbach R., and Kipen H. Bioaerosols and sick building syndrome: particles, inflammation, and allergy. Curr Opin Allergy Clin Immunol 5 (2005) 135-139
129. Straus D., Cooley J., Wong W., et al. Studies on the role of fungi in sick building syndrome. Arch Environ Health 58 8 (2003) 475-478
130. Wilson S., and Straus D. The presence of fungi associated with sick building syndrome in North American zoological institutions. J Zoo Wildl Med 33 4 (2002) 322-327
131. Cooley J., Wong W., Jumper C., et al. Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med 55 (1998) 579-584
132. Baldo J.V., Ahmad L., and Ruff R. Neuropsychological performance of patients following mold exposure. Appl Neuropsychol 9 4 (2002) 193-202
133. Handal G., Leiner M.A., Cabrera M., et al. Children symptoms before and after knowing about an indoor fungal contamination. Indoor Air 14 2 (2004) 87-91
134. Khalili B., and Bardana E. International mold toxicity: fact or fiction? A clinical review of 50 cases. Ann Allergy 95 (2005) 239-246
135. Khalili B., Montanaro M., and Bardana E. Indoor mold and your patient's health: from suspicion to confirmation. J Respir Dis 26 120 (2005) 520-525
136. Platt S., Martin C., Hunt S., et al. Damp housing, mould growth and symptomatic health state. Br Med J 298 (1989) 1673-1678
137. Dales R., Zwanenberg H., Burnett R., et al. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol 134 (1991) 196-203
138. Brunekreef B., Dockery D., Speizer F., et al. Home dampness and respiratory morbidity in children. Am Rev Respir Dis 140 (1989) 1363-1367
139. Hynes P., Brugge D., Osgood N., et al. Investigations into the indoor environment and respiratory health in Boston public housing. Rev Environ Health 19 3-4 (2004) 271-289
140. Horner W. The damp building effect: understanding needed, not more debate. Ann Allergy 94 (2005) 213-215
141. Dekker C., Dales R., Bartlett S., et al. Childhood asthma and the indoor environment. Chest 100 (1991) 922-926
142. Li C.-S., and Hsu L.-Y. Home dampness and childhood respiratory symptoms in a subtropical climate. Arch Environ Health 51 1 (1996) 42-46
143. Yang C.-Y., Cheng M.-F., Tsai S.-S., et al. Effects of indoor environmental factors on risk for acute otitis media in a subtropical area. J Toxicol Environ Health A 56 (1999) 111-119
144. Strachan D., and Elton R. Relationship between respiratory morbidity in children and the home environment. Fam Pract 3 3 (1986) 137-142
145. Jedrychowski W., and Flak E. Separate and combined effects of the outdoor and indoor air quality on chronic respiratory symptoms adjusted for allergy among preadolescent children. Int J Occup Med Environ Health 11 1 (1998) 19-35
146. Peat J.K., Dickerson J., and Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy 53 2 (1998) 120-128
147. Jaakkola J., Jaakkola N., and Ruotsalainen R. Home dampness and molds as determinants of respiratory symptoms and asthma in pre-school children. J Expo Anal Environ Epidemiol 3 Suppl 1 (1993) 129-142
148. Strachan D., and Sanders C. Damp housing and childhood asthma; respiratory effects of indoor air and temperature and relative humidity. J Epidemiol Community Health 43 (1989) 7-14
149. Bornehag C., Blomquist G., Gyntelberg F., et al. Dampness in buildings and health. Indoor Air 11 (2001) 72-86
150. Santilli J. Health effects of mold exposure in public schools. Curr Allergy Asthma Rep 2 (2002) 460-467
151. Rylander R., Norrhall M., Engdahl U., et al. Airways inflammation, atopy, and (1→3)-β-D-glucan. Am J Respir Crit Care Med 158 (1998) 1685-1687
152. Meklin T., Husman T., Vepsalainen M., et al. Indoor air microbes and respiratory symptoms of children in moisture damaged and reference schools. Indoor Air 12 (2002) 175-183
153. Meklin T., Potus T., Pekkanen J., et al. Effects of moisture-damage repairs on microbial exposure and symptoms in schoolchildren. Indoor Air 15 Suppl 10 (2005) 40-47
154. Savilahti R., Uitti J., Laippala P., et al. Respiratory morbidity among children following renovation of a water-damaged school. Arch Environ Health 55 6 (2000) 405-410
155. Savilahti R., Uitti J., Roto P., et al. Increased prevalence of atopy among children exposed to mold in a school building. Allergy 56 2 (2001) 175-179
156. Meyer H., Wurtz H., Suadicani P., et al. Molds in floor dust and building-related symptoms in adolescent school children. Indoor Air 14 (2004) 65-72
157. Meyer H., Wurtz H., Suadicani P., et al. Molds in floor dust and building-related symptoms among adolescent school children: a problem for boys only?. Indoor Air 15 Suppl 10 (2005) 17-24
158. Scheel C., Rosing W., and Farone A. Possible sources of sick building syndrome in a Tennessee middle school. Arch Environ Health 56 5 (2001) 413-419
159. Bartlett K., Kennedy S., Brauer M., et al. Evaluation and a predictive model of airborne fungal concentrations in school classrooms. Ann Occup Hyg 48 6 (2004) 547-554